Mapping the human genetic architecture of COVID-19 | Nature
KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease - Kidney International
Covid-19 testing data can help schools stay open this year - STAT
Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease | SpringerLink
Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease | SpringerLink
Joshua D. Wallach (@JoshuaDWallach) / Twitter
Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis - The Lancet Global Health
Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease | SpringerLink
FSI | SHP - Health Policy News
Program | INTERSPEECH 2021
Better health projections lead to better health policy, says new SHP faculty member - FSI
When cost-effective interventions are unaffordable: Integrating cost- effectiveness and budget impact in priority setting for global health programs
Program | INTERSPEECH 2021
2019 Scientific Program - 2019 - Journal of Ultrasound in Medicine - Wiley Online Library
KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease - Kidney International
Jeremy D. Goldhaber-Fiebert's 235 research works in Biology and Medicine
Joshua Salomon – Prevention Policy Modeling Lab
People in Economics: Data-Driven in: Finance & Development Volume 0058 Issue 004 (2021)
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples | Nature Communications
Why to eliminate/eradicate: costs, benefits and economic evaluations of... | Download Table
An open repository of real-time COVID-19 indicators | PNAS
Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease | SpringerLink